About
Katie Grabek, PhD, is the co-founder and Chief Scientific Officer of Fauna Bio, a biotechnology company using comparative genomics and hibernation biology to identify human drug targets. She earned her PhD in Human Medical Genetics at the University of Colorado Anschutz Medical Campus and trained as a postdoctoral scholar in computational biology in Carlos Bustamante's lab at Stanford. Her public profile is centered on scientific research, company building, and longevity/biotech ecosystem participation, including Fauna Bio's obesity-target discovery collaboration with Eli Lilly.
Areas of interest
longevitybiotechdrug discoverycomparative genomicscomputational biologyhuman geneticshibernation biologyAI in therapeuticsmetabolic diseasecardiovascular disease